These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 32677286)

  • 21. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of pre-diagnostic symptoms did not differ between LRRK2-related, GBA-related and idiopathic patients with Parkinson's disease.
    Liu SY; Zheng Z; Gu ZQ; Wang CD; Tang BS; Xu YM; Ma JH; Zhou YT; Feng T; Chen SD; Chan P;
    Parkinsonism Relat Disord; 2018 Dec; 57():72-76. PubMed ID: 30119933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
    Westenberger A; Skrahina V; Usnich T; Beetz C; Vollstedt EJ; Laabs BH; Paul JJ; Curado F; Skobalj S; Gaber H; Olmedillas M; Bogdanovic X; Ameziane N; Schell N; Aasly JO; Afshari M; Agarwal P; Aldred J; Alonso-Frech F; Anderson R; Araújo R; Arkadir D; Avenali M; Balal M; Benizri S; Bette S; Bhatia P; Bonello M; Braga-Neto P; Brauneis S; Cardoso FEC; Cavallieri F; Classen J; Cohen L; Coletta D; Crosiers D; Cullufi P; Dashtipour K; Demirkiran M; de Carvalho Aguiar P; De Rosa A; Djaldetti R; Dogu O; Dos Santos Ghilardi MG; Eggers C; Elibol B; Ellenbogen A; Ertan S; Fabiani G; Falkenburger BH; Farrow S; Fay-Karmon T; Ferencz GJ; Fonoff ET; Fragoso YD; Genç G; Gorospe A; Grandas F; Gruber D; Gudesblatt M; Gurevich T; Hagenah J; Hanagasi HA; Hassin-Baer S; Hauser RA; Hernández-Vara J; Herting B; Hinson VK; Hogg E; Hu MT; Hummelgen E; Hussey K; Infante J; Isaacson SH; Jauma S; Koleva-Alazeh N; Kuhlenbäumer G; Kühn A; Litvan I; López-Manzanares L; Luxmore M; Manandhar S; Marcaud V; Markopoulou K; Marras C; McKenzie M; Matarazzo M; Merello M; Mollenhauer B; Morgan JC; Mullin S; Musacchio T; Myers B; Negrotti A; Nieves A; Nitsan Z; Oskooilar N; Öztop-Çakmak Ö; Pal G; Pavese N; Percesepe A; Piccoli T; Pinto de Souza C; Prell T; Pulera M; Raw J; Reetz K; Reiner J; Rosenberg D; Ruiz-Lopez M; Ruiz Martinez J; Sammler E; Santos-Lobato BL; Saunders-Pullman R; Schlesinger I; Schofield CM; Schumacher-Schuh AF; Scott B; Sesar Á; Shafer SJ; Sheridan R; Silverdale M; Sophia R; Spitz M; Stathis P; Stocchi F; Tagliati M; Tai YF; Terwecoren A; Thonke S; Tönges L; Toschi G; Tumas V; Urban PP; Vacca L; Vandenberghe W; Valente EM; Valzania F; Vela-Desojo L; Weill C; Weise D; Wojcieszek J; Wolz M; Yahalom G; Yalcin-Cakmakli G; Zittel S; Zlotnik Y; Kandaswamy KK; Balck A; Hanssen H; Borsche M; Lange LM; Csoti I; Lohmann K; Kasten M; Brüggemann N; Rolfs A; Klein C; Bauer P
    Brain; 2024 Aug; 147(8):2652-2667. PubMed ID: 39087914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo.
    Albanese F; Mercatelli D; Finetti L; Lamonaca G; Pizzi S; Shimshek DR; Bernacchia G; Morari M
    Neurobiol Dis; 2021 Nov; 159():105487. PubMed ID: 34419621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocerebrosidase 1 and leucine-rich repeat kinase 2 in Parkinson disease and interplay between the two genes.
    Lee CY; Menozzi E; Chau KY; Schapira AHV
    J Neurochem; 2021 Dec; 159(5):826-839. PubMed ID: 34618942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-exome sequencing in early-onset Parkinson's disease among ethnic Chinese.
    Li N; Wang L; Zhang J; Tan EK; Li J; Peng J; Duan L; Chen C; Zhou D; He L; Peng R
    Neurobiol Aging; 2020 Jun; 90():150.e5-150.e11. PubMed ID: 32171587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
    Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM
    Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Landscape of Monogenic Parkinson's Disease in Populations of Non-European Ancestry: A Narrative Review.
    Koros C; Bougea A; Simitsi AM; Papagiannakis N; Angelopoulou E; Pachi I; Antonelou R; Bozi M; Stamelou M; Stefanis L
    Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age at onset in LRRK2-associated PD is modified by SNCA variants.
    Botta-Orfila T; Ezquerra M; Pastor P; Fernández-Santiago R; Pont-Sunyer C; Compta Y; Lorenzo-Betancor O; Samaranch L; Martí MJ; Valldeoriola F; Calopa M; Fernández M; Aguilar M; de Fabregas O; Hernández-Vara J; Tolosa E
    J Mol Neurosci; 2012 Sep; 48(1):245-7. PubMed ID: 22669510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's disease: from monogenic forms to genetic susceptibility factors.
    Lesage S; Brice A
    Hum Mol Genet; 2009 Apr; 18(R1):R48-59. PubMed ID: 19297401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.
    Pont-Sunyer C; Tolosa E; Caspell-Garcia C; Coffey C; Alcalay RN; Chan P; Duda JE; Facheris M; Fernández-Santiago R; Marek K; Lomeña F; Marras C; Mondragon E; Saunders-Pullman R; Waro B;
    Mov Disord; 2017 May; 32(5):726-738. PubMed ID: 28370517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients.
    Tan YY; Wu L; Zhao ZB; Wang Y; Xiao Q; Liu J; Wang G; Ma JF; Chen SD
    Parkinsonism Relat Disord; 2014 Mar; 20(3):308-13. PubMed ID: 24398085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 10-Year Community-Based Study of Leucine-Rich Repeat Kinase 2 G2385R Carriers' Conversion to Parkinson's Disease.
    Wang P; Pan J; Luo Q; Chen J; Tang H; Chen S; Ma J
    Mov Disord; 2022 Aug; 37(8):1767-1772. PubMed ID: 35733392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in Sex-Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism.
    Ortega RA; Bressman SB; Raymond D; Ozelius LJ; Katsnelson V; Leaver K; Swan MC; Shanker V; Miravite J; Wang C; Bennett SAL; Saunders-Pullman R
    Mov Disord; 2022 Nov; 37(11):2217-2225. PubMed ID: 36054306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression.
    Ortega RA; Wang C; Raymond D; Bryant N; Scherzer CR; Thaler A; Alcalay RN; West AB; Mirelman A; Kuras Y; Marder KS; Giladi N; Ozelius LJ; Bressman SB; Saunders-Pullman R
    JAMA Netw Open; 2021 Apr; 4(4):e215845. PubMed ID: 33881531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.
    Alcalay RN; Caccappolo E; Mejia-Santana H; Tang M-; Rosado L; Orbe Reilly M; Ruiz D; Ross B; Verbitsky M; Kisselev S; Louis E; Comella C; Colcher A; Jennings D; Nance M; Bressman S; Scott WK; Tanner C; Mickel S; Andrews H; Waters C; Fahn S; Cote L; Frucht S; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer R; Marsh L; Hiner B; Siderowf A; Payami H; Molho E; Factor S; Ottman R; Clark LN; Marder K
    Neurology; 2012 May; 78(18):1434-40. PubMed ID: 22442429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of posttranslational modifications of α-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors.
    Pajarillo E; Rizor A; Lee J; Aschner M; Lee E
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):1992-2000. PubMed ID: 30481588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's disease in a dish - Using stem cells as a molecular tool.
    Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
    Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.